
Joe Raedle/Getty Images News
- A day after the U.S. FDA issued recommendations on the virus strains to include when manufacturing influenza vaccines for the 2025-2026 season, Sanofi (NASDAQ:SNY) on Friday said it has already started production.
- The strains chosen by the agency already match